BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27281448)

  • 1. Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.
    de Mey C; Koelsch S; Richter E; Pohlmann T; Sousa R
    Drug Res (Stuttg); 2016 Jul; 66(7):384-92. PubMed ID: 27281448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties.
    Fischer J; Pschorn U; Vix JM; Peil H; Aicher B; Müller A; de Mey C
    Arzneimittelforschung; 2002; 52(4):256-63. PubMed ID: 12040968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept.
    Schutz A; Gund HJ; Pschorn U; Aicher B; Peil H; Müller A; de Mey C; Gillissen A
    Arzneimittelforschung; 2002; 52(3):194-9. PubMed ID: 11963647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation.
    de Mey C; Peil H; Kölsch S; Bubeck J; Vix JM
    Arzneimittelforschung; 2008; 58(11):557-68. PubMed ID: 19137906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.
    de Mey C; Patel J; Lakha DR; Richter E; Koelsch S
    Drug Res (Stuttg); 2015 Dec; 65(12):658-67. PubMed ID: 25782170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of sore throat pain with ambroxol-containing lozenges. Results of a pharmacy supported patient questionnaire].
    Gillissen A; Hinkel U
    Med Monatsschr Pharm; 2005 Nov; 28(11):399-403. PubMed ID: 16309023
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis.
    Chenot JF; Weber P; Friede T
    BMC Fam Pract; 2014 Mar; 15():45. PubMed ID: 24621446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambroxol lozenges: new drug. Sore throat: better to just suck on hard candy.
    Prescrire Int; 2009 Apr; 18(100):52. PubMed ID: 19585713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine 8 mg sore throat lozenges in the treatment of acute pharyngitis. A new therapeutic option investigated in comparison to placebo treatment.
    Wonnemann M; Helm I; Stauss-Grabo M; Röttger-Luer P; Tran CT; Canenbley R; Donath F; Nowak H; Schug BS; Blume HH
    Arzneimittelforschung; 2007; 57(11):689-97. PubMed ID: 18193690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flurbiprofen 8.75 mg lozenges for treating sore throat symptoms: a randomized, double-blind, placebo-controlled study.
    Schachtel BP; Shephard A; Shea T; Sanner K; Savino L; Rezuke J; Schachtel E; Aspley S
    Pain Manag; 2016 Nov; 6(6):519-529. PubMed ID: 27734772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study.
    Schachtel B; Aspley S; Shephard A; Shea T; Smith G; Schachtel E
    Trials; 2014 Jul; 15():263. PubMed ID: 24988909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study.
    Donath F; Mallefet P; Garreffa S; Furcha R
    Trials; 2018 Dec; 19(1):679. PubMed ID: 30541606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis.
    Sousa R; Lakha DR; Brette S; Hitier S
    Pulm Ther; 2019 Dec; 5(2):201-211. PubMed ID: 32026411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model.
    Schachtel BP; Homan HD; Gibb IA; Christian J
    Clin Pharmacol Ther; 2002 May; 71(5):375-80. PubMed ID: 12011823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinflammatory properties of ambroxol.
    Beeh KM; Beier J; Esperester A; Paul LD
    Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis.
    Weckmann G; Hauptmann-Voß A; Baumeister SE; Klötzer C; Chenot JF
    Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28869700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial (DoriPha).
    Palm J; Fuchs K; Stammer H; Schumacher-Stimpfl A; Milde J;
    Int J Clin Pract; 2018 Dec; 72(12):e13272. PubMed ID: 30329199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial.
    McNally D; Simpson M; Morris C; Shephard A; Goulder M
    Int J Clin Pract; 2010 Jan; 64(2):194-207. PubMed ID: 19849767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.
    McNally D; Shephard A; Field E
    J Pharm Pharm Sci; 2012; 15(2):281-94. PubMed ID: 22579007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.